CONSOLIDATED AND COMBINED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss	Non-Controlling Interests in Equity of Consolidated Subsidiaries
Beginning balance at Dec. 31, 2022	$ 524,794	$ 994	$ 911,599	$ (60,837)	$ (300,133)	$ (26,829)
Increase (Decrease) in Partners' Capital [Roll Forward]
Net loss	(159,750)			(121,336)		(38,414)
Other comprehensive loss	121,618				121,618
Comprehensive loss	(38,132)	$ 0	0	(121,336)	121,618	(38,414)
Acquisition of consolidated subsidiary			953
Acquisition of consolidated subsidiary	(4,448)					(3,495)
Distributions to non-controlling interests	(1,647)					(1,647)
Issuance of common shares (in shares)		12
Issuance of common shares	28		16
Dividends and accretion of redeemable preferred stock	(62,400)		(62,400)
Dividends declared on common stock	(12,372)		(12,372)
Settlement of equity instruments	(2,163)		(1,629)			(534)
Equity-based compensation	9,199		9,710			(511)
Ending balance at Dec. 31, 2023	412,859	$ 1,006	843,971	(182,173)	(178,515)	(71,430)
Increase (Decrease) in Partners' Capital [Roll Forward]
Net loss	(266,064)			(223,645)		(42,419)
Other comprehensive loss	21,464				21,464
Comprehensive loss	(244,600)	$ 0	0	(223,645)	21,464	(42,419)
Distributions to non-controlling interests	(15,039)					(15,039)
Issuance of common shares (in shares)		133
Issuance of common shares	552		419
Dividends and accretion of redeemable preferred stock	(70,814)		(70,814)
Dividends declared on common stock	(13,124)		(13,124)
Settlement of equity instruments	(3,332)		(2,906)			(426)
Equity-based compensation	8,636		6,835			1,801
Ending balance at Dec. 31, 2024	75,138	$ 1,139	764,381	(405,818)	(157,051)	(127,513)
Increase (Decrease) in Partners' Capital [Roll Forward]
Net loss	(152,054)			(107,174)		(44,880)
Other comprehensive loss	66,433				66,433
Comprehensive loss	(85,621)	$ 0	0	(107,174)	66,433	(44,880)
Distributions to non-controlling interests	(1,314)					(1,314)
Issuance of common shares (in shares)		24
Issuance of common shares	2,716		2,692
Issuance of warrants	1,012		1,012
Issuance of Manager options	7,358		7,358
Dividends and accretion of redeemable preferred stock	(100,229)		(100,229)
Dividends declared on common stock	(13,831)		(13,831)
Settlement of equity instruments	(6,050)		(4,106)			(1,944)
Equity-based compensation	11,230		3,140			8,090
Ending balance at Dec. 31, 2025	(146,237)	$ 1,163	623,771	$ (512,992)	$ (90,618)	$ (167,561)
Increase (Decrease) in Partners' Capital [Roll Forward]
Adjustments to Additional Paid in Capital, Other	$ (36,646)		$ (36,646)